MSKCC
Memorial Sloan Kettering Cancer Center Portfolio holdings
AUM $24.6M
1-Year Return
10.16%
This Quarter Return
-5.2%
1 Year Return
+10.16%
3 Year Return
-15.77%
5 Year Return
–
10 Year Return
–
AUM
$160M
AUM Growth
+$7.54M
(+4.9%)
Cap. Flow
+$23.1M
Cap. Flow
% of AUM
14.37%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
2
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Caribou Biosciences
CRBU
|
+$16.1M |
| 2 |
Illumina
ILMN
|
+$6.98M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 86.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Royalty Pharma
RPRX
$15.2B
| $96.9M | 60.36% |
2,680,644
| – | – |
|
2
VanEck Gold Miners ETF
GDX
$20.5B
| $21.8M | 13.56% |
738,500
| – | – |
|
|
3
Caribou Biosciences
CRBU
$170M
| $16.1M | 10.03% |
+674,196
| New | +$16.1M |
|
4
Oric Pharmaceuticals
ORIC
$1.04B
| $12.6M | 7.85% |
602,272
| – | – |
|
|
5
Illumina
ILMN
$15.5B
| $6.98M | 4.35% |
+17,677
| New | +$6.98M |
|
6
Y-mAbs Therapeutics
YMAB
$391M
| $6.19M | 3.86% |
216,916
| – | – |
|